<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370506</journal-id>
<journal-id journal-id-type="pubmed-jr-id">433</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Sci.</journal-id>
<journal-title-group>
<journal-title>The American journal of the medical sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9629</issn>
<issn pub-type="epub">1538-2990</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30384950</article-id>
<article-id pub-id-type="pmc">6268214</article-id>
<article-id pub-id-type="doi">10.1016/j.amjms.2018.08.005</article-id>
<article-id pub-id-type="manuscript">NIHMS1507741</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DEVELOPMENT OF THE PEDIATRIC GUT MICROBIOME: IMPACT ON HEALTH AND DISEASE</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ihekweazu</surname>
<given-names>Faith D.</given-names>
</name>
<degrees>M.D., M.S.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Versalovic</surname>
<given-names>James</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children’s Hospital, 1102 Bates St., Houston, TX, 77030, USA. <email>faith.ihekweazu@bcm.edu</email></aff>
<aff id="A2"><label>2</label>Pediatric Pathology and Immunology, Baylor College of Medicine, Texas Children’s Hospital 1102 Bates St., Houston, TX, 77030, USA. <email>jamesv@bcm.edu</email>.</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: James Versalovic, M.D., Ph.D., Department of Pathology, Texas Children’s Hospital, Feigin Tower, 1102 Bates St., FT Ste. 830, Houston, TX 77030, USA. Phone: 832-824-2213 <email>jamesv@bcm.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P40">Conflict of Interest Statement: FDI has no conflicts to disclose. J.V. receives unrestricted research support from BioGaia AB.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>356</volume>
<issue>5</issue>
<fpage>413</fpage>
<lpage>423</lpage>
<!--elocation-id from pubmed: 10.1016/j.amjms.2018.08.005-->
<abstract id="ABS1">
<p id="P1">The intestinal microbiota are important in proper human growth and development before and after birth, during infancy and childhood. Microbial composition may yield insights into the temporal development of microbial communities and vulnerabilities to disorders of microbial ecology such as recurrent <italic>Clostridium difficile</italic> infection. Discoveries of key microbiome features of carbohydrate and amino acid metabolism are lending new insights into possible new therapies or preventative strategies for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). In this review, we summarize the current understanding of the development of the pediatric gastrointestinal microbiome, the influence of the microbiome on the developing brain through the gut-brain axis, and the impact of dysbiosis on the development of disease. Microbial dysbiosis will be explored in the context of pediatric allergy and asthma, recurrent <italic>C. difficile</italic> infection, IBD, IBS, and metabolic disorders. The central premise is that the human intestinal microbiome plays a vital role throughout human life beginning in the prenatal period and extending throughout childhood in health and disease.</p>
</abstract>
<kwd-group>
<kwd>children</kwd>
<kwd>early life</kwd>
<kwd>gut-brain axis</kwd>
<kwd>gut microbes</kwd>
<kwd>microbiota</kwd>
<kwd>neonatal</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>